Wave Life Sciences initiated with Overweight at J.P. Morgan Source: Seekingalpha
Month: September 2024
GE Healthcare initiated with Neutral at J.P. Morgan Source: Seekingalpha
Eli Lilly bets $409M for AI-focused drug discovery Source: Seekingalpha
Lisata jumps on FDA orphan drug status for bile duct cancer drug Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Kits Eyecare announces $10.15M secondary offering Source: Seekingalpha
Fanhua and Shanghai Biotecan Pharmaceuticals enters into cooperation agreement Source: Seekingalpha
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
